Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma - Concepedia

Concepedia

Publication | Open Access

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

DOI Full Paper Access

811

Citations

10

References

2013

Year

Antoni Ribas, Richard Kefford, Margaret Marshall, Cornelis J.A. Punt, John B.A.G. Haanen, Maribel Mármol, Claus Garbe, Helen Gogas, Jacob Schachter, Gerald P. Linette,

Journal of Clinical Oncology

Abstract

This study failed to demonstrate a statistically significant survival advantage of treatment with tremelimumab over standard-of-care chemotherapy in first-line treatment of patients with metastatic melanoma.

References

	Year	Citations

Page 1